PBYI - Puma Biotechnology EPS beats by $0.46 beats on revenue
Puma Biotechnology (NASDAQ:PBYI): Q2 Non-GAAP EPS of $0.32 beats by $0.46; GAAP EPS of -$0.13 beats by $0.14. Revenue of $53.4M (-24.4% Y/Y) beats by $1.1M. Press Release
For further details see:
Puma Biotechnology EPS beats by $0.46, beats on revenue